跳至主要内容
临床试验/CTRI/2021/09/036776
CTRI/2021/09/036776尚未招募4 期

To study the therapeutic efficacy of oral ketamine in depression

GMC RH Patiala0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male and female patients aged 18-65 years with Diagnostic and Statistical Manual-5 (DSM-5) diagnosis of major depressive episode without psychotic features.
  • 2. Patients who will be medically stable .
  • 3. Patients who have given written informed consent.

排除标准

  • 1. History of chronic psychosis or drug induced psychosis of any kind.
  • 2. Current DSM-5 diagnosis of drug abuse/dependence in the last six months and a negative drug screen at baseline.
  • 3. Pregnant women, lactating mothers, surgically-sterile women or women who agree to continue using applicable birth control throughout the trial. All women of child-bearing potential must have a negative urine pregnancy test.
  • 4. History of seizures, renal insufficiency or congestive heart failure

研究者

发起方
GMC RH Patiala

相似试验

Therapeutic efficacy of oral ketamine in Depressio | 临床试验